Molecular profiling identifies targeted therapy opportunities in pediatric solid cancerAlanna J. Church, Katherine A. Janeway, Brian D. Crompton et al.|Nature Medicine|2022Cited by 65
Long-term follow-up of the first in human post-transcriptional genetic silencing of BCL11A in sickle cell disease in a phase 1 pilot and feasibility trialErica B. Esrick, David A. Williams, Wendy B. London et al.|Blood|2025Cited by 1